AUO [AU OPTRONICS] 6-K: (Original Filing)
[]
HIMX [Himax Technologies] 6-K: (Original Filing)
[Himax Technologies, Inc. Pre-announces Preliminary Unaudited Second Quarter 2020 Financial Results Revenues, Gross Margin and EPS all Exceed Guidance th th TAINAN, Taiwan, July 06, 2020 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless]
XIN [Xinyuan Real Estate] 6-K: (Original Filing)
[XINYUAN REAL ESTATE CO., LTD. 2020 RESTRICTED STOCK UNIT PLAN 1 Purpose. The purpose of the Xinyuan Real Estate Co., Ltd. 2020 Restricted Stock Unit Plan (the "Plan") is to secure for Xinyuan Real Estate Co., Ltd., a Cayman Islands holding company and its successors and assigns (the "Company"), and ]
AMCN [AIRNET TECHNOLOGY] 6-K: (Original Filing)
[AirNet Announces Receipt of Deficiency Letter from Nasdaq Under the Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company has until August 31, 2020 (that is, 60 calendar days from the date of the Deficiency Letter) to submit to Nasdaq a plan (the “Compliance Plan”) to regain compliance with the Nasdaq L]
WB [WEIBO] 6-K: (Original Filing)
[WEIBO CORPORATION NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To Be Held on August 13, 2020 Company AGM On Thursday, August 13, 2020, Weibo Corporation, a Cayman Islands company (the Record Date Only shareholders registered in the Companys register of members at the close of business on June]
SPU [Future FinTech] 10-Q: (Original Filing)
[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q (CEO) CERTIFICATION I, Shanchun Huang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Future FinTech Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a mat]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial Beijing-July 6, 2020 — Sinovac Biotech Ltd. ( “Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced an update to its pre]
LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)
[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) Issuer (the (Stock Code: 2628) US$1,280,000,000 CORE TIER 2 CAPITAL SECURITIES (the Securities) (Stock Code: 5540) NOTICE ON COMPLETION OF REDEM]
